After extensive research, I believe Sarepta Therapeutics Inc (NASDAQ:SRPT) will likely breakout this week. The chart has consolidated for a long period, slowly falling from over $60 after the last fantastic bit of drug news. The breakout trend line seen in the chart below continues to be hammered and should give way on the next move up. I also believe there will be likely drug news in the next few weeks which will propel the stock to as high as $45. That is a 50% upside target. This company is on the cutting edge of multiple biotech drug treatments and at its current valuation, offers an amazing opportunity. I am looking to buy some this week, the second the stock crosses above the breakout trend line.